Turnstone stops TIL studies; GH Research’s $150M offering

Plus, news about Auron Therapeutics, Akribion Therapeutics, Enveric Biosciences and Valerio Therapeutics:

Turnstone Biologics to discontinue TIL studies, “review strategic alternatives”: The company

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

American Medical Association Releases Language of First New Current Procedural Terminology Code for Psychedelic Therapies | Psychedelic Invest

COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that the American Medical

July 11, 2023

NCCN guidelines establish an equitable standard of care for cancer outcomes

Today, the National Comprehensive Cancer Network® (NCCN®)-;an alliance of leading cancer centers-;convened a policy summit to examine how geography impacts cancer outcomes.

June 16, 2023

NHS urged to expand TEER access for all mitral regurgitation patients

A life-saving medical procedure called Trans-catheter Edge-to-edge Repair (or TEER) for a common heart complaint is not available to many patients it could help.

May 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.